Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

To eat or not to eat: Is fasting still necessary before heart procedures?
As one may expect, patient satisfaction was considerably higher for individuals who did not have to fast for a minimum of six hours prior to treatment. There were no other significant differences.
Pulmonary embolism thrombectomy use increases by more than 700%
Medicare claims submitted between 2017 and 2022 showed a 712% increase in thrombectomy for pulmonary embolism (PE) and a 137% increase in thrombectomy for deep vein thrombosis (DVT).
Private equity-backed Medline files for IPO
The company, founded in 1966, has been providing supplies to cardiac surgery suites and cath labs for decades.
Key takeaways for interventional cardiology from TCT 2025
B. Hadley Wilson, MD, talked to Cardiovascular Business about several standout late-breaking clinical trials presented at TCT 2025. Topics of those trials included drug-coated balloons, TAVR valve durability, pulmonary embolism treatments and much more.
FDA clears new AI-enabled coronary plaque analysis software
Circle Cardiovascular Imaging, a Canadian medtech company, received the key approval for its cvi42 | Plaque platform.

CT angiography paired with FFR can inform decisions for certain CAD patients

CT angiography (CTA), coupled with fractional flow reserve (FFR), demonstrated an ability to detect functionally significant lesions in patients with multivessel coronary artery disease (CAD).

Noninvasive FFR assessment can guide revascularization decisions for multivessel CAD

A noninvasive imaging technique combined with fractional flow reserve (FFR) showed the potential to detect functionally significant lesions in patients with multivessel coronary artery disease (CAD), according to a study published June 11 in the Journal of the American College of Cardiology.

Researcher highlights importance of imaging, biomarkers in cardio-oncology

A scientist at the American Society of Clinical Oncology (ASCO)’s annual meeting discussed how cardiac imaging and biomarker measurements could improve care for cancer survivors.

Leading medical provider awarded prestigious European radiation safety ranking

Affidea, the leading European provider of diagnostic imaging, outpatient and cancer care services, announced that 11 of its centers have been awarded "5 Stars" on the EuroSafe Wall by the European Society of Radiology.

ASCO 2018: How cardiac imaging, biomarkers could improve cancer patient care

Paaladinesh "Dinesh" Thavendiranathan, MD, a scientist at Canada’s Toronto General Hospital Research Institute, recently discussed how cardiac imaging and biomarkers can significantly improve cancer patient care at the American Society of Clinical Oncology (ASCO) annual meeting.

Physicians prefer stress tests to angiography in states with malpractice caps

Physicians practicing in states that implemented damage caps for malpractice claims were less likely to use angiography and more likely to use noninvasive stress testing in coronary artery disease patients.

Mark Cuban helped raise $7.5M for a biomagnetic imaging startup

Best known for his appearances on the TV show “Shark Tank,” Mark Cuban was part of a group of investors who helped raise millions for the non-invasive biomagnetic imaging startup.

Philips receives U.S. FDA 510(k) clearance for its Ingenia Elition MR solution

With first U.S. commercial installation at Hennepin Healthcare, the Philips Ingenia Elition performs MRI exam times up to 50 percent faster with no compromise in image quality.

Cardiac Imaging

To eat or not to eat: Is fasting still necessary before heart procedures?

Pulmonary embolism thrombectomy use increases by more than 700%

Private equity-backed Medline files for IPO

Key takeaways for interventional cardiology from TCT 2025

FDA clears new AI-enabled coronary plaque analysis software